(Q66397313)
Statements
A Phase 2 Clinica Study: Efficacy and Safety of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation (English)
0 references
27 September 2016
0 references
December 2017
0 references
55
0 references
18 year
0 references
75 year
0 references